Bottom line
Is PSCNX a good fund? The bottom line
PSCNX is the Institutional Class share class of Penn Capital Special Situations Small Cap Equity Fund, an actively managed small-cap mutual fund from Tortoise.
Annual fees run 1.09% — about $109 a year on every $10,000 invested, more expensive than 59% of small-cap funds we track.
It returned +8.0% over one year, +11.5% a year over five years (as of Dec 31, 2024, per its prospectus).
With $108 million in net assets and 84 holdings, its largest position is Ouster Inc (2.6%) and the top 10 make up 20.2% of the portfolio.
What stands out
- 5-year return beat 93% of category peers
- No front-end sales load
Updated Nov 19, 2026
What PSCNX invests in
The Penn Capital Special Situations Small Cap Equity Fund (the ?Fund?) seeks to provide capital appreciation.
The Fund seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets in the equity securities of small-capitalization companies. Small-capitalization companies are defined for this purpose as companies with market capitalizations at the time of purchase between the lesser of $100 million or the market capitalization of the smallest company included in the Bloomberg US 2000 Index and the greater of $6 billion or the market capitalization of the largest company included in the Bloomberg US 2000 Index. As of October 31, 2025, the minimum and maximum market capitalizations included in the Bloomberg US 2000 Index were approximately $20 million and $14.4 billion, respectively. The Fund is not required to sell equity securities whose market values appreciate or depreciate outside this market capitalization range. In selecting investments…
From the fund's prospectus (filed Jan 5, 2026).
PSCNX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| PSCNX | +8.0% | +11.5% | — |
| Small-Cap median | +7.6% | +7.0% | +9.2% |
Source: Fund prospectus, as of Dec 31, 2024
What PSCNX costs
On a $10,000 investment, PSCNX's 1.09% expense ratio costs about $109 a year. The prospectus estimates $2,008 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.
PSCNX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Ouster Inc OUST | 2.64% |
| 2 | ACM Research Inc ACMR | 2.50% |
| 3 | Mirum Pharmaceuticals Inc MIRM | 2.13% |
| 4 | US Bank Mmda - Usbfs 2 | 2.00% |
| 5 | RXO Inc RXO | 1.98% |
| 6 | Constellium SE CSTM | 1.85% |
| 7 | Lumen Technologies Inc LUMN | 1.84% |
| 8 | Legence Corp LGN | 1.83% |
| 9 | Wolfspeed Inc WOLF | 1.73% |
| 10 | Ligand Pharmaceuticals Inc LGND | 1.70% |
Source: SEC Form N-PORT, period ended May 31, 2026
The top 10 make up 20.2% of the fund. See all top 25 holdings and asset mix →